化疗和胆道癌的全身治疗模式的转变
Wattana Leowattana1, Tawithep Leowattana2, Pathomthep Leowattana3
1Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Rachatawee 10400, Bangkok, Thailand. wattana.leo@mahidol.ac.th.
World journal of gastrointestinal oncology
|June 30, 2023
概括
胆道癌 (BTC) 的治疗选择有限. 较新的向疗法和免疫检查点抑制剂在改善BTC患者的治疗结果方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 胆道癌 (BTC) 往往是晚期诊断的,导致预后不佳.
- 目前的第一线治疗依赖于凝胺和西斯,第二线治疗选择有限.
研究的目的:
- 对胆道癌症的现有景观和新兴疗法进行审查.
- 突出针对性治疗和免疫检查点抑制剂在管理BTC方面的潜力.
主要方法:
- 对BTC治疗的当前临床实践和最近临床试验数据的审查.
- 对包括FGFR2,NTRK和IDH1抑制剂在内的向疗法的分析.
- 免疫检查点抑制剂 (ICI) 的评估及其在BTC中的作用.
主要成果:
- 向疗法在特定的BTC患者子组中显示出显著的疗效.
- 免疫检查点抑制剂目前仅限于在微观卫星不稳定性高的患者的第一线使用.
- 托帕兹-1试验表明组合疗法的积极结果.
结论:
- 包括ICI在内的新兴向药物和组合疗法可能代表BTC管理的范式转变.
- 由于目前治疗方案的有限的向突变和毒性,较新的药物可能发挥关键作用.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Chronic Pancreatitis II: Collaborative Care
115
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
115
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573


